Victor Sanjuan-Mangas

Valencia, VC 46100, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications

Comparison of Metrics for Investigating Bioequivalence in Onset of Action in Incurred Bioequivalence Studies.

Comparison of Metrics for Investigating Bioequivalence in Onset of Action in Incurred Bioequivalence Studies.

Journal: Pharmaceutics
Published: July 13, 2026

PBPK model of carbamazepine and its metabolite for bioequivalence assessment: prioritizing early exposure and single-dose study designs.

PBPK model of carbamazepine and its metabolite for bioequivalence assessment: prioritizing early exposure and single-dose study designs.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: May 05, 2026

Model-Based Design of Sustained-Release Formulations of Anti-TNF-α Monoclonal Antibodies for Intravitreal Administration.

Model-Based Design of Sustained-Release Formulations of Anti-TNF-α Monoclonal Antibodies for Intravitreal Administration.

Journal: Pharmaceutics
Published: February 20, 2026

Impact of shelf-life on the pharmaceutical equivalence assessment of a hydrocortisone semisolid W/O emulsion: Evaluation of rheological, structural, and release properties.

Impact of shelf-life on the pharmaceutical equivalence assessment of a hydrocortisone semisolid W/O emulsion: Evaluation of rheological, structural, and release properties.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: February 05, 2026

Forecasting the Biological Effect of PEGylated-rHuEPO Candidates in Chronic Kidney Disease Patients using a Middle-out Translation Approach.

Forecasting the Biological Effect of PEGylated-rHuEPO Candidates in Chronic Kidney Disease Patients using a Middle-out Translation Approach.

Journal: Pharmaceutical research
Published: September 27, 2025

Elesclomol-copper therapy improves neurodevelopment in two children with Menkes disease.

Elesclomol-copper therapy improves neurodevelopment in two children with Menkes disease.

Journal: The Journal of clinical investigation
Published: July 29, 2025

Leveraging Two-Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK Models.

Leveraging Two-Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK Models.

Journal: Pharmaceutical statistics
Published: July 21, 2025

Comparison of dissolution profiles: 90 % confidence intervals of different f2 estimators using bootstrap methodology versus the Euclidean Distance of the Non-standardized Expected (EDNE) values.

Comparison of dissolution profiles: 90 % confidence intervals of different f2 estimators using bootstrap methodology versus the Euclidean Distance of the Non-standardized Expected (EDNE) values.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: May 15, 2025

A physiologically based pharmacokinetic model to describe [89Zr]Zr-DFO-Adalimumab specific activity after intravitreal administration to rats with endotoxin-induced uveitis.

A physiologically based pharmacokinetic model to describe [89Zr]Zr-DFO-Adalimumab specific activity after intravitreal administration to rats with endotoxin-induced uveitis.

Journal: International journal of pharmaceutics
Published: April 16, 2025

Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence Assessment.

Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence Assessment.

Journal: Pharmaceutics
Published: February 26, 2025

Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs.

Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs.

Journal: Clinical pharmacokinetics
Published: December 31, 2024

Solubility-Limited Absorption Identified by a Simplified PBPK Model for the Prediction of Positive Food Effect for BCS II/IV Drugs.

Solubility-Limited Absorption Identified by a Simplified PBPK Model for the Prediction of Positive Food Effect for BCS II/IV Drugs.

Journal: Clinical pharmacokinetics
Published: December 31, 2024
Showing 1-12 of 80

Last Updated: 09/26/2026